论文部分内容阅读
目的:探讨经尿道前列腺汽化电切除术(transurethralelectrovaporizationoftheprostate,TUVP)与经尿道前列腺电切术(transurethralelectroresectionoftheprostate,TURP)联合治疗良性前列腺增生症(benignprostatichyperplasia,BPH)的疗效。方法:2001年5月至2004年10月,运用TUVP联合TURP治疗BPH168例。结果:平均手术时间55min,平均失血量80mL,术中输血3例,无经尿道电切综合征发生。随访132例,时间3～30个月。国际前列腺症状评分由术前(23.3±4.6)分下降至术后(8.6±2.8)分(t=31.36,P<0.01),生活质量评分由术前(5.2±0.6)分下降至术后(1.8±0.5)分(t=50.02,P<0.01),最大尿流率由术前(5.3±3.9)mL/s上升至术后(15.2±5.3)mL/s(t=17.29,P<0.01)。残余尿量由术前(68.8±13.4)mL下降至术后(19.2±14.8)mL(t=28.54,P<0.01)。结论:TUVP联合TURP治疗BPH,安全性高,疗效显著,值得推广。
Objective: To investigate the efficacy of transurethralelectrovaporization of hepprostate (TUVP) and transurethralelectroresection ofheprostate (TURP) in the treatment of benign prostatic hyperplasia (BPH). Methods: From May 2001 to October 2004, 168 cases of BPH were treated with TUVP and TURP. Results: The mean operation time was 55 minutes, the mean blood loss was 80ml, 3 cases of intraoperative blood transfusion, and no transurethral resection syndrome occurred. Follow-up 132 cases, time 3 to 30 months. The International Prostate Symptom Score decreased from preoperative (23.3 ± 4.6) to postoperative (8.6 ± 2.8) points (t = 31.36, P <0.01), and the quality of life score decreased from preoperative (5.2 ± 0.6) to postoperative 1.8 ± 0.5) (t = 50.02, P <0.01). The maximum urinary flow rate increased from 5.3 ± 3.9 mL / s to 15.2 ± 5.3 mL / s preoperatively (t = 17.29, P 0.01 ). The residual urine volume decreased from 68.8 ± 13.4 mL to 19.2 ± 14.8 mL (t = 28.54, P <0.01). Conclusion: TUVP combined with TURP treatment of BPH, high safety, significant effect, it is worth promoting.